MS Pharma, a family-run generics firm operating across the Middle East, Turkey and Africa, said it has struck a deal to acquire 100% of the outstanding shares of Greek drugmaker Genepharm. The company called the acquisition an “important milestone in our growth plans.”
Based in Jordan’s capital Amman, MS Pharma says it is aiming to enlarge its geographic footprint and reach more customers...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?